Advertisement

Topics

Search Results for "BIAL Pharmaceuticals"

00:09 EDT 4th May 2016 | BioPortfolio

Matching Channels

Massachusetts

Located in the north-east corner of the USA, Massachusetts, has the third highest GDP of any state in America and is also a hotspot for the biotechnology industry. In addition to the globally renown...

The Top 100 Drugs

The pharmaceutical industry is massive, both in range of products and in financial values. These are the top 200 drugs (ranked in descending order according to total sales in 20010, $), and the co...

Datamonitor - aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapidly evolving marketplace

The Datamonitor Group aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapi...

Michigan

Surrounded by the Great Lakes in the north east of the US, Michigan hosts many high profile biotechnology companies and has become an industry hotbed. In 1993 MichBio was formed, as an industry tr...

Covidien

Covidien is the 9th largest global medical device company with annual sales in 2010 of almost $8 billion. Covidien was originally Tyco Healthcare, until June 2007, and has seen year-on-year growth s...

Matching News

Bial’s Zebinix meets Phase III endpoints in new epilepsy study

Bial Portela, Portugal’s largest drugmaker, has released positive results for a pivotal Phase III non-inferiority…

Bial Trial Tragedy: No Safety Clue From Similar Products

Though officially unconfirmed, it is presumed that the fatty acid amide hydrolase inhibitor at the center of the Bial clinical trial disaster is BIA 10-2474, which was in Phase I development for the t...

'Clear statistical reservations' surround Bial's fatal clinical trial

The Royal Statistical Society has questioned the design of the trial of Bial's candidate painkiller BIA-102474-101 in which one person died and others were hospitalised last month .

Ph I trial of Bial pain drug sees one volunteer brain-dead

In a serious safety failure during a Phase I trial of a pain drug under development by Bial Portela,…

Ph I trial of Bial pain drug sees one volunteer die

In a serious safety failure during a Phase I trial of a pain drug under development by Bial Portela,…

Bial Drug Sparks French Clinical Trial Tragedy

Portugal-based Bial-Portela & Ca. S.A. is the manufacturer of the experimental medicine that sent six male volunteers in a trial of the drug to hospital in France, one of whom is on life support and i...

Animal study indicated BIA 10-2474 was safe for human trials, says Bial

Preclinical data indicated BIA 10-2474 was safe to take into human trials according to Bial, which says dogs put down in toxicology studies had pulmonary lesions not injuries caused by the drug.

French Experts Ask Bial For More Preclinical Data On FAAH Inhibitor

The expert committee set up by the French medicines regulator ANSM to look into the preclinical data on Bial's FAAH inhibitor, BIA 10-2474, following the death of a volunteer and the hospitalization o...

Matching PubMed Articles

Removal of pharmaceuticals from secondary effluents by an electro-peroxone process.

This study compared the removal of pharmaceuticals from secondary effluents of wastewater treatment plants (WWTPs) by conventional ozonation and the electro-peroxone (E-peroxone) process, which involv...

Increased acute toxicity to fish caused by pharmaceuticals in hospital effluents in a pharmaceutical mixture and after solar irradiation.

Hospital effluents are an important source of residual drugs and other classes of pharmaceuticals in aquatic environments. The raw wastewater from the studied hospital exhibited acute toxicity to vert...

Ranking Prescribed Pharmaceuticals in Terms of Environmental Risk: Inclusion of Hospital Data and the Importance of Regular Review.

A newly available dataset on pharmaceuticals used in Scottish hospitals enabled an Environmental Risk Assessment that includes hospital consumption of pharmaceuticals, as previous UK rankings have bee...

Uptake, depuration, and bioconcentration of two pharmaceuticals, roxithromycin and propranolol, in Daphnia magna.

The objective of the present study was to investigate the uptake, depuration, and bioconcentration of two pharmaceuticals, roxithromycin (ROX) and propranolol (PRP), in Daphnia magna via aqueous expos...

Acute toxicities of pharmaceuticals toward green algae. mode of action, biopharmaceutical drug disposition classification system and quantile regression models.

The acute toxicities of 36 pharmaceuticals towards green algae were estimated from a set of quantile regression models representing the first global quantitative structure-activity relationships. The ...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement